Multi-omics and biomarker discovery
3 European H2020 organizations list this as part of their work.
Most active in this area
- KLINIKUM DER TECHNISCHEN UNIVERSITÄT MÜNCHEN (TUM KLINIKUM)
TU Munich's university hospital: translational research in oncology, neuroscience, and precision diagnostics with strong ERC track record and advanced imaging capabilities.
“SOUND (multi-omics), TAXINOMISIS (omics + computational modeling), MultipleMS (multiomics for MS), AIMS-2-TRIALS (biomarkers for autism), and EJP RD (rare disease data/omics) reflect growing investment in data-driven precision medicine.”
DE49 projects - PIRKANMAAN HYVINVOINTIALUE
Finnish regional healthcare authority contributing clinical populations and health data to EU research on disease screening, exposome, and precision prevention.
“TAXINOMISIS uses pharmacogenomics, HEDIMED applies multi-omics sensoring, and HEAP integrates metabolomics and microbiomics data.”
FI5 projects - ISLENSK ERFDAGREINING EHF
Icelandic genomics company providing population-scale genetic data and biobank analytics for psychiatric, cardiovascular, and precision medicine research.
“PainFACT applies proteomics, metabolomics, and brain imaging alongside genetics; REALMENT integrates genotype data with clinical trial results.”
IS4 projects